MedTrace Logo

The OBSTACLE Hypoglycemia Study (MK-0000-158)

NCT00907881 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1069

Last updated 2015-04-21

Study results available
· View outcomes & findings →

Summary

This study will assess the correlation between glycemic control and the hypoglycemia symptom score in patients with Type 2 diabetes, 12 weeks after addition of a sulfonylurea to an ongoing regime of oral hypoglycemic agents.

Conditions

Interventions

DRUG

Sulfonylurea

The dose and frequency of administration of study drug (sulfonylurea) was decided by the investigator according to the individual need of each participant.

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-05-31
Completion
2010-05-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00907881 on ClinicalTrials.gov